Gene,rsId,Ref,Alt,Effect,Alleles Frequency,Number of citation,Publications,Clinical Significant,ClinVar Accession,Cytogenetic location,Variant name,Disease name,Synonyms
ERCC4,rs121913049,C,T,"missense_variant,coding_sequence_variant","T=0.000481 (121/251312, GnomAD_exome).T=0.000711 (150/210942, ALFA).T=0.000511 (62/121398, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs121913049#publications,Pathogenic-Likely-Pathogenic,RCV000415873.11,16p13.12,NM_005236.3(ERCC4):c.2395C>T (p.Arg799Trp),none provided,MedGen: CN517202
ERCC4,rs121913049,C,T,"missense_variant,coding_sequence_variant","T=0.000481 (121/251312, GnomAD_exome).T=0.000711 (150/210942, ALFA).T=0.000511 (62/121398, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs121913049#publications,Pathogenic,RCV000467658.8,16p13.12,NM_005236.3(ERCC4):c.2395C>T (p.Arg799Trp),"Xeroderma pigmentosum, group F (XPF)
                    ","XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XERODERMA PIGMENTOSUM VI; XP, GROUP F; See all synonyms [MedGen]"
ERCC4,rs121913049,C,T,"missense_variant,coding_sequence_variant","T=0.000481 (121/251312, GnomAD_exome).T=0.000711 (150/210942, ALFA).T=0.000511 (62/121398, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs121913049#publications,Pathogenic,RCV000766208.1,16p13.12,NM_005236.3(ERCC4):c.2395C>T (p.Arg799Trp),"XFE progeroid syndrome (XFEPS)
                    ",MONDO: MONDO:0012590; MedGen: C1970416; OMIM: 610965
ERCC4,rs121913049,C,T,"missense_variant,coding_sequence_variant","T=0.000481 (121/251312, GnomAD_exome).T=0.000711 (150/210942, ALFA).T=0.000511 (62/121398, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs121913049#publications,Likely-Pathogenic,RCV001034542.1,16p13.12,NM_005236.3(ERCC4):c.2395C>T (p.Arg799Trp),"Hutchinson-Gilford syndrome (HGPS)
                    ",Progerin-producing progeroid laminopathy
ERCC4,rs121913049,C,T,"missense_variant,coding_sequence_variant","T=0.000481 (121/251312, GnomAD_exome).T=0.000711 (150/210942, ALFA).T=0.000511 (62/121398, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs121913049#publications,Likely-Pathogenic,RCV001391196.1,16p13.12,NM_005236.3(ERCC4):c.2395C>T (p.Arg799Trp),Carcinoma of pancreas,"PANCREATIC ACINAR CARCINOMA; PANCREATIC CARCINOMA; Pancreatic cancer, somatic; See all synonyms [MedGen]"
ERCC4,rs121913049,C,T,"missense_variant,coding_sequence_variant","T=0.000481 (121/251312, GnomAD_exome).T=0.000711 (150/210942, ALFA).T=0.000511 (62/121398, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs121913049#publications,Likely-Pathogenic,RCV002257360.2,16p13.12,NM_005236.3(ERCC4):c.2395C>T (p.Arg799Trp),"Xeroderma pigmentosum (XP)
                    ",Xeroderma pigmentosa
ERCC4,rs121913050,G,C,"2KB_upstream_variant,upstream_transcript_variant,genic_upstream_transcript_variant,missense_variant,coding_sequence_variant","A=0.000008 (2/264690, TOPMED).C=0.000007 (1/140130, GnomAD).C=0.00000 (0/78702, PAGE_STUDY)",1,https://www.ncbi.nlm.nih.gov/snp/rs121913050,Pathogenic,RCV000018049.29,16p13.12,NM_005236.3(ERCC4):c.458G>C (p.Arg153Pro),"XFE progeroid syndrome (XFEPS)
                    ",MONDO: MONDO:0012590; MedGen: C1970416; OMIM: 610965
ERCC4,rs147105770,C,T,"missense_variant,coding_sequence_variant","T=0.000085 (14/164138, ALFA).T=0.000066 (8/121150, ExAC).T=0.00010 (8/78702, PAGE_STUDY)",3,https://www.ncbi.nlm.nih.gov/snp/rs147105770,Likely-Pathogenic,RCV000049250.34,16p13.12,NM_005236.3(ERCC4):c.1765C>T (p.Arg589Trp),"Xeroderma pigmentosum, type F/cockayne syndrome",MONDO: MONDO:0800313; MedGen: C3806565
ERCC4,rs147105770,C,T,"missense_variant,coding_sequence_variant","T=0.000085 (14/164138, ALFA).T=0.000066 (8/121150, ExAC).T=0.00010 (8/78702, PAGE_STUDY)",3,https://www.ncbi.nlm.nih.gov/snp/rs147105770,Pathogenic,RCV000700109.5,16p13.12,NM_005236.3(ERCC4):c.1765C>T (p.Arg589Trp),"Xeroderma pigmentosum, group F (XPF)
                    ","XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XERODERMA PIGMENTOSUM VI; XP, GROUP F; See all synonyms [MedGen]"
ERCC4,rs147105770,C,T,"missense_variant,coding_sequence_variant","T=0.000085 (14/164138, ALFA).T=0.000066 (8/121150, ExAC).T=0.00010 (8/78702, PAGE_STUDY)",3,https://www.ncbi.nlm.nih.gov/snp/rs147105770,Pathogenic,RCV000762956.2,16p13.12,NM_005236.3(ERCC4):c.1765C>T (p.Arg589Trp),"Xeroderma pigmentosum, group F (XPF)
                    ","XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XERODERMA PIGMENTOSUM VI; XP, GROUP F; See all synonyms [MedGen]"
ERCC4,rs147105770,C,T,"missense_variant,coding_sequence_variant","T=0.000085 (14/164138, ALFA).T=0.000066 (8/121150, ExAC).T=0.00010 (8/78702, PAGE_STUDY)",3,https://www.ncbi.nlm.nih.gov/snp/rs147105770,Pathogenic,RCV002222373.2,16p13.12,NM_005236.3(ERCC4):c.1765C>T (p.Arg589Trp),"Xeroderma pigmentosum (XP)
                    ",Xeroderma pigmentosa
ERCC4,rs149364215,C,A,"missense_variant,coding_sequence_variant","T=0.000007 (1/140228, GnomAD).A=0.00001 (1/78700, PAGE_STUDY).T=0.00004 (1/28258, 14KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs149364215,Pathogenic,RCV000049245.29,16p13.12,NM_005236.3(ERCC4):c.2065C>A (p.Arg689Ser),Fanconi anemia complementation group Q,MONDO: MONDO:0014108; MedGen: C3808988; Orphanet: 84; OMIM: 615272
ERCC4,rs149364215,C,A,"missense_variant,coding_sequence_variant","T=0.000007 (1/140228, GnomAD).A=0.00001 (1/78700, PAGE_STUDY).T=0.00004 (1/28258, 14KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs149364215,Likely-Pathogenic,RCV001067959.5,16p13.12,NM_005236.3(ERCC4):c.2065C>A (p.Arg689Ser),"Xeroderma pigmentosum, group F (XPF)
                    ","XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XERODERMA PIGMENTOSUM VI; XP, GROUP F; See all synonyms [MedGen]"
ERCC4,rs397509402,T,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant,2KB_upstream_variant,upstream_transcript_variant","C=0.000004 (1/251344, GnomAD_exome).C=0.00000 (0/78702, PAGE_STUDY).C=0.000 (0/660, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs397509402,Pathogenic,RCV000049247.30,16p13.12,NM_005236.3(ERCC4):c.689T>C (p.Leu230Pro),Fanconi anemia complementation group Q,MONDO: MONDO:0014108; MedGen: C3808988; Orphanet: 84; OMIM: 615272
ERCC4,rs397509403,T,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant,2KB_upstream_variant,upstream_transcript_variant","C=0.000007 (1/140270, GnomAD).C=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs397509403,Pathogenic,RCV000049248.29,16p13.12,NM_005236.3(ERCC4):c.706T>C (p.Cys236Arg),"Xeroderma pigmentosum, type F/Cockayne syndrome",MONDO: MONDO:0800313; MedGen: C3806565
ERCC4,rs397509403,T,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant,2KB_upstream_variant,upstream_transcript_variant","C=0.000007 (1/140270, GnomAD).C=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs397509403,Likely-Pathogenic,RCV001568088.3,16p13.12,NM_005236.3(ERCC4):c.706T>C (p.Cys236Arg),none provided,MedGen: C3661900
ERCC5,rs9514067,G,T,"missense_variant,coding_sequence_variant,stop_gained","G=0.002214 (586/264690, TOPMED).G=0.07266 (7222/99398, ALFA).G=0.00299 (235/78700, PAGE_STUDY)",4,https://www.ncbi.nlm.nih.gov/snp/rs9514067#publications,Likely-Pathogenic,RCV000190581.3,13q33.1,NM_000123.4(ERCC5):c.3238G>T (p.Gly1080Ter),"Xeroderma pigmentosum, group G (XPG)
                    ","XP, GROUP G; Xeroderma pigmentosum VII; Xeroderma pigmentosum complementation group G; See all synonyms [MedGen]"
ERCC5,rs121434570,G,T,"missense_variant,stop_gained,coding_sequence_variant","T=0.000045 (12/264690, TOPMED).T=0.000029 (4/140258, GnomAD).T=0.00008 (6/78692, PAGE_STUDY)",1,https://www.ncbi.nlm.nih.gov/snp/rs121434570,Pathogenic,RCV000018034.25,13q33.1,NM_000123.4(ERCC5):c.2878G>T (p.Glu960Ter),"Xeroderma pigmentosum, group G (XPG)
                    ","XP, GROUP G; Xeroderma pigmentosum VII; Xeroderma pigmentosum complementation group G; See all synonyms [MedGen]"
ERCC5,rs121434570,G,T,"missense_variant,stop_gained,coding_sequence_variant","T=0.000045 (12/264690, TOPMED).T=0.000029 (4/140258, GnomAD).T=0.00008 (6/78692, PAGE_STUDY)",1,https://www.ncbi.nlm.nih.gov/snp/rs121434570,Pathogenic,RCV000587956.1,13q33.1,NM_000123.4(ERCC5):c.2878G>T (p.Glu960Ter),"Xeroderma pigmentosum (XP)
                    ",Xeroderma pigmentosa
ERCC5,rs121434572,C,T,"synonymous_variant,missense_variant,stop_gained,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000008 (2/251376, GnomAD_exome).T=0.000007 (1/140142, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs121434572,Pathogenic,RCV000018038.25,13q33.1,NM_000123.4(ERCC5):c.787C>T (p.Arg263Ter),"Xeroderma pigmentosum group g/Cockayne syndrome (XPG/CS)
                    ","XERODERMA PIGMENTOSUM, TYPE G/COCKAYNE SYNDROME"
ERCC5,rs121434574,C,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/251420, GnomAD_exome).T=0.000008 (1/121400, ExAC)",1,https://www.ncbi.nlm.nih.gov/snp/rs121434574,Pathogenic,RCV000018040.28,13q33.1,NM_000123.4(ERCC5):c.215C>A (p.Pro72His),"Xeroderma pigmentosum group G/Cockayne syndrome (XPG/CS)
                    ","XERODERMA PIGMENTOSUM, TYPE G/COCKAYNE SYNDROME"
ERCC5,rs121434575,T,C,"missense_variant,coding_sequence_variant","C=0.00001 (1/78700, PAGE_STUDY).C=0.000 (0/660, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs121434575,Pathogenic,RCV000018041.29,13q33.1,NM_000123.4(ERCC5):c.2573T>C (p.Leu858Pro),"Xeroderma pigmentosum, group G (XPG)
                    ","XP, GROUP G; Xeroderma pigmentosum VII; Xeroderma pigmentosum complementation group G; See all synonyms [MedGen]"
ERCC5,rs121434577,C,T,"missense_variant,stop_gained,coding_sequence_variant","G=0.000011 (3/264690, TOPMED).G=0.000014 (2/140228, GnomAD).T=0.00000 (0/78702, PAGE_STUDY)",1,https://www.ncbi.nlm.nih.gov/snp/rs121434577,Pathogenic,RCV000018046.29,13q33.1,NM_000123.4(ERCC5):c.406C>T (p.Gln136Ter),"Xeroderma pigmentosum, group G (XPG)
                    ","XP, GROUP G; Xeroderma pigmentosum VII; Xeroderma pigmentosum complementation group G; See all synonyms [MedGen]"
ERCC5,rs267607280,G,C,"missense_variant,coding_sequence_variant","C=0.00000 (0/78702, PAGE_STUDY)",1,https://www.ncbi.nlm.nih.gov/snp/rs267607280,Pathogenic,RCV000034377.30,13q33.1,NM_000123.4(ERCC5):c.2904G>C (p.Trp968Cys),"Xeroderma pigmentosum, group G (XPG)
                    ","XP, GROUP G; Xeroderma pigmentosum VII; Xeroderma pigmentosum complementation group G; See all synonyms [MedGen]"
ERCC5,rs267607281,C,A,"intron_variant,missense_variant,coding_sequence_variant","A=0.00000 (0/78700, PAGE_STUDY).A=0.000 (0/660, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs267607281,Pathogenic,RCV000034376.26,13q33.1,NM_000123.4(ERCC5):c.83C>A (p.Ala28Asp),"Xeroderma pigmentosum, group G (XPG)
                    ","XP, GROUP G; Xeroderma pigmentosum VII; Xeroderma pigmentosum complementation group G; See all synonyms [MedGen]"
ETV6,rs587776710,-,insGGG,"inframe_indel,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs587776710#publications,Pathogenic,RCV000009548.4,12p13.2,NM_001987.5(ETV6):c.1307_1308insGGG (p.His436delinsGlnGly),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
ETV6,rs724159945,C,T,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs724159945,Pathogenic,RCV000149802.2,12p13.2,NM_001987.5(ETV6):c.1195C>T (p.Arg399Cys),Hematologic neoplasm,Hematologic cancer; Hematological neoplasm; Hematological malignancies
ETV6,rs724159945,C,T,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs724159945,Pathogenic,RCV000157609.6,12p13.2,NM_001987.5(ETV6):c.1195C>T (p.Arg399Cys),"Thrombocytopenia 5 (THC5)
                    ","THROMBOCYTOPENIA 5 WITH INCREASED SUSCEPTIBILITY TO MALIGNANCY; THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 5"
ETV6,rs724159945,C,T,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs724159945,Pathogenic,RCV001824288.2,12p13.2,NM_001987.5(ETV6):c.1195C>T (p.Arg399Cys),none provided,MedGen: CN517202
ETV6,rs724159946,G,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/264690, TOPMED).A=0.000007 (1/140216, GnomAD).A=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs724159946,Pathogenic,RCV000149803.2,12p13.2,NM_001987.5(ETV6):c.1106G>A (p.Arg369Gln),Hematologic neoplasm,Hematologic cancer; Hematological neoplasm; Hematological malignancies
ETV6,rs724159946,G,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/264690, TOPMED).A=0.000007 (1/140216, GnomAD).A=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs724159946,Pathogenic,RCV000157610.7,12p13.2,NM_001987.5(ETV6):c.1106G>A (p.Arg369Gln),"Thrombocytopenia 5 (THC5)
                    ","THROMBOCYTOPENIA 5 WITH INCREASED SUSCEPTIBILITY TO MALIGNANCY; THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 5"
ETV6,rs724159947,C,T,"missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs724159947,Likely-Pathogenic,RCV000149804.2,12p13.2,NM_001987.5(ETV6):c.641C>T (p.Pro214Leu),Hematologic neoplasm,Hematologic cancer; Hematological neoplasm; Hematological malignancies
ETV6,rs724159947,C,T,"missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs724159947,Pathogenic,RCV000157611.8,12p13.2,NM_001987.5(ETV6):c.641C>T (p.Pro214Leu),"Thrombocytopenia 5 (THC5)
                    ","THROMBOCYTOPENIA 5 WITH INCREASED SUSCEPTIBILITY TO MALIGNANCY; THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 5"
ETV6,rs724159947,C,T,"missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs724159947,Pathogenic,RCV001281572.2,12p13.2,NM_001987.5(ETV6):c.641C>T (p.Pro214Leu),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
ETV6,rs724159947,C,T,"missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs724159947,Pathogenic,RCV001818340.3,12p13.2,NM_001987.5(ETV6):c.641C>T (p.Pro214Leu),none provided,MedGen: CN517202
ETV6,rs786205226,A,G,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs786205226,Pathogenic,RCV000170497.5,12p13.2,NM_001987.5(ETV6):c.1252A>G (p.Arg418Gly),"Thrombocytopenia 5 (THC5)
                    ","THROMBOCYTOPENIA 5 WITH INCREASED SUSCEPTIBILITY TO MALIGNANCY; THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 5"
EXO1,rs750915959,C,delC,"stop_gained,genic_upstream_transcript_variant,coding_sequence_variant","delC=0.000011 (3/264690, TOPMED).delC=0.000008 (2/251384, GnomAD_exome).delC=0.000014 (2/140240, GnomAD)",non citation,,Likely-Pathogenic,RCV000658555.8,1q43,NM_130398.4(EXO1):c.136del (p.Lys45_Leu46insTer),none provided,MedGen: CN517202
EXT1,rs11546829,G,T,"stop_gained,synonymous_variant,coding_sequence_variant","A=0.237024 (62738/264690, TOPMED).A=0.263764 (66198/250974, GnomAD_exome).A=0.236250 (33092/140072, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs11546829#publications,Pathogenic,RCV000692001.4,8q24.11,NM_000127.3(EXT1):c.1065C>A (p.Cys355Ter),"Multiple congenital exostosis (EXT)
                    ",DIAPHYSEAL ACLASIS; MULTIPLE CARTILAGINOUS EXOSTOSES; OSTEOCHONDROMATOSIS; See all synonyms [MedGen]
EXT1,rs119103287,C,A,"coding_sequence_variant,missense_variant","T=0.000004 (1/251146, GnomAD_exome).T=0.000008 (1/121188, ExAC).T=0.00004 (1/28258, 14KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs119103287,Pathogenic,RCV000002601.13,8q24.11,NM_000127.3(EXT1):c.1019G>T (p.Arg340Leu),"Multiple congenital exostosis (EXT)
                    ",DIAPHYSEAL ACLASIS; MULTIPLE CARTILAGINOUS EXOSTOSES; OSTEOCHONDROMATOSIS; See all synonyms [MedGen]
EXT1,rs119103287,C,A,"coding_sequence_variant,missense_variant","T=0.000004 (1/251146, GnomAD_exome).T=0.000008 (1/121188, ExAC).T=0.00004 (1/28258, 14KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs119103287,Pathogenic,RCV001003502.1,8q24.11,NM_000127.3(EXT1):c.1019G>T (p.Arg340Leu),"Exostoses, multiple, type 1 (EXT1)
                    ","EXOSTOSES, MULTIPLE, TYPE I"
EXT1,rs119103287,C,T,"coding_sequence_variant,missense_variant","T=0.000004 (1/251146, GnomAD_exome).T=0.000008 (1/121188, ExAC).T=0.00004 (1/28258, 14KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs119103287,Pathogenic,RCV000254839.3,8q24.11,NM_000127.3(EXT1):c.1019G>A (p.Arg340His),none provided,MedGen: CN517202
EXT1,rs119103287,C,T,"coding_sequence_variant,missense_variant","T=0.000004 (1/251146, GnomAD_exome).T=0.000008 (1/121188, ExAC).T=0.00004 (1/28258, 14KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs119103287,Pathogenic,RCV000630812.7,8q24.11,NM_000127.3(EXT1):c.1019G>A (p.Arg340His),"Multiple congenital exostosis (EXT)
                    ",DIAPHYSEAL ACLASIS; MULTIPLE CARTILAGINOUS EXOSTOSES; OSTEOCHONDROMATOSIS; See all synonyms [MedGen]
EXT1,rs119103287,C,T,"coding_sequence_variant,missense_variant","T=0.000004 (1/251146, GnomAD_exome).T=0.000008 (1/121188, ExAC).T=0.00004 (1/28258, 14KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs119103287,Pathogenic,RCV001263553.2,8q24.11,NM_000127.3(EXT1):c.1019G>A (p.Arg340His),"Exostoses, multiple, type 1 (EXT1)
                    ","EXOSTOSES, MULTIPLE, TYPE I"
EXT1,rs119103288,C,T,"coding_sequence_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs119103288,Pathogenic,RCV000002604.10,8q24.11,NM_000127.3(EXT1):c.1016G>A (p.Gly339Asp),"Multiple congenital exostosis (EXT)
                    ",DIAPHYSEAL ACLASIS; MULTIPLE CARTILAGINOUS EXOSTOSES; OSTEOCHONDROMATOSIS; See all synonyms [MedGen]
EXT1,rs119103288,C,T,"coding_sequence_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs119103288,Pathogenic,RCV001003501.1,8q24.11,NM_000127.3(EXT1):c.1016G>A (p.Gly339Asp),"Exostoses, multiple, type 1 (EXT1)
                    ","EXOSTOSES, MULTIPLE, TYPE I"
EXT1,rs119103289,G,T,"coding_sequence_variant,stop_gained,synonymous_variant","T=0.000 (0/478, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs119103289,Pathogenic,RCV000002605.2,8q24.11,NM_000127.3(EXT1):c.357C>A (p.Tyr119Ter),"Exostoses, multiple, type 1 (EXT1)
                    ","EXOSTOSES, MULTIPLE, TYPE I"
EXT1,rs119103290,G,A,"coding_sequence_variant,missense_variant","A=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs119103290,Pathogenic,RCV000002606.8,8q24.11,NM_000127.3(EXT1):c.1018C>T (p.Arg340Cys),"Multiple congenital exostosis (EXT)
                    ",DIAPHYSEAL ACLASIS; MULTIPLE CARTILAGINOUS EXOSTOSES; OSTEOCHONDROMATOSIS; See all synonyms [MedGen]
EXT1,rs119103290,G,A,"coding_sequence_variant,missense_variant","A=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs119103290,Pathogenic-Likely-Pathogenic,RCV000255752.3,8q24.11,NM_000127.3(EXT1):c.1018C>T (p.Arg340Cys),none provided,MedGen: CN517202
EXT1,rs119103290,G,A,"coding_sequence_variant,missense_variant","A=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs119103290,Pathogenic,RCV001003500.1,8q24.11,NM_000127.3(EXT1):c.1018C>T (p.Arg340Cys),"Exostoses, multiple, type 1 (EXT1)
                    ","EXOSTOSES, MULTIPLE, TYPE I"
EXT1,rs119103290,G,C,"coding_sequence_variant,missense_variant","A=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs119103290,Likely-Pathogenic,RCV001270018.1,8q24.11,NM_000127.3(EXT1):c.1018C>G (p.Arg340Gly),none provided,MedGen: CN517202
EXT1,rs786205593,C,T,"missense_variant,stop_gained,coding_sequence_variant","G=0.00004 (1/28258, 14KJPN).G=0.00006 (1/16760, 8.3KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs786205593,Likely-Pathogenic,RCV000171418.1,8q24.11,NM_000127.3(EXT1):c.2132G>A (p.Trp711Ter),none provided,MedGen: CN517202
EXT1,rs786205593,C,T,"missense_variant,stop_gained,coding_sequence_variant","G=0.00004 (1/28258, 14KJPN).G=0.00006 (1/16760, 8.3KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs786205593,Pathogenic,RCV001057521.3,8q24.11,NM_000127.3(EXT1):c.2132G>A (p.Trp711Ter),"Multiple congenital exostosis (EXT)
                    ",DIAPHYSEAL ACLASIS; MULTIPLE CARTILAGINOUS EXOSTOSES; OSTEOCHONDROMATOSIS; See all synonyms [MedGen]
EXT2,rs121918279,C,T,"missense_variant,stop_gained,coding_sequence_variant","G=0.000004 (1/249458, GnomAD_exome).T=0.00000 (0/78702, PAGE_STUDY).A=0.00005 (1/18930, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121918279#publications,Pathogenic,RCV000002576.8,11p11.2,NM_207122.2(EXT2):c.514C>T (p.Gln172Ter),"Exostoses, multiple, type 2","EXOSTOSES, MULTIPLE, TYPE II"
EXT2,rs121918279,C,T,"missense_variant,stop_gained,coding_sequence_variant","G=0.000004 (1/249458, GnomAD_exome).T=0.00000 (0/78702, PAGE_STUDY).A=0.00005 (1/18930, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121918279#publications,Pathogenic,RCV000255256.4,11p11.2,NM_207122.2(EXT2):c.514C>T (p.Gln172Ter),none provided,MedGen: CN517202
EXT2,rs121918279,C,T,"missense_variant,stop_gained,coding_sequence_variant","G=0.000004 (1/249458, GnomAD_exome).T=0.00000 (0/78702, PAGE_STUDY).A=0.00005 (1/18930, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121918279#publications,Pathogenic,RCV000762843.1,11p11.2,NM_207122.2(EXT2):c.514C>T (p.Gln172Ter),"Exostoses, multiple, type 2","EXOSTOSES, MULTIPLE, TYPE II"
EXT2,rs121918279,C,T,"missense_variant,stop_gained,coding_sequence_variant","G=0.000004 (1/249458, GnomAD_exome).T=0.00000 (0/78702, PAGE_STUDY).A=0.00005 (1/18930, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121918279#publications,Pathogenic,RCV000850054.1,11p11.2,NM_207122.2(EXT2):c.514C>T (p.Gln172Ter),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
EXT2,rs121918280,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/78696, PAGE_STUDY).A=0.00000 (0/14710, ALFA).C=0.00000 (0/14710, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121918280,Pathogenic,RCV000002578.7,11p11.2,NM_207122.2(EXT2):c.679G>A (p.Asp227Asn),"Exostoses, multiple, type 2","EXOSTOSES, MULTIPLE, TYPE II"
EXT2,rs121918280,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/78696, PAGE_STUDY).A=0.00000 (0/14710, ALFA).C=0.00000 (0/14710, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121918280,Pathogenic,RCV000791300.1,11p11.2,NM_207122.2(EXT2):c.679G>A (p.Asp227Asn),Seizures-scoliosis-macrocephaly syndrome,"Seizures, scoliosis, and macrocephaly syndrome; SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME"
EXT2,rs121918280,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/78696, PAGE_STUDY).A=0.00000 (0/14710, ALFA).C=0.00000 (0/14710, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121918280,Pathogenic,RCV001091958.7,11p11.2,NM_207122.2(EXT2):c.679G>A (p.Asp227Asn),none provided,MedGen: CN517202
EXT2,rs121918281,C,G,"stop_gained,synonymous_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121918281,Pathogenic,RCV000002579.4,11p11.2,NM_207122.2(EXT2):c.666C>G (p.Tyr222Ter),"Exostoses, multiple, type 2 (EXT2)
                    ","EXOSTOSES, MULTIPLE, TYPE II"
EXT2,rs140075817,T,G,"missense_variant,coding_sequence_variant","G=0.000268 (71/264690, TOPMED).G=0.000354 (89/251194, GnomAD_exome).G=0.000541 (104/192346, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs140075817,Pathogenic,RCV000203245.4,11p11.2,NM_207122.2(EXT2):c.260T>G (p.Met87Arg),Seizures-scoliosis-macrocephaly syndrome,"Seizures, scoliosis, and macrocephaly syndrome; SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME"
EXT2,rs376292686,C,T,"missense_variant,coding_sequence_variant","T=0.000076 (20/264690, TOPMED).T=0.000048 (12/251052, GnomAD_exome).T=0.000093 (13/140286, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs376292686,Pathogenic,RCV000203245.4,11p11.2,NM_207122.2(EXT2):c.260T>G (p.Met87Arg),Seizures-scoliosis-macrocephaly syndrome,"Seizures, scoliosis, and macrocephaly syndrome; SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME"
EZH2,rs193921146,AAT,delAAT,"coding_sequence_variant,inframe_deletion",None,1,https://www.ncbi.nlm.nih.gov/snp/rs193921146#publications,Pathogenic,RCV000023117.5,7q36.1,NM_004456.5(EZH2):c.457_459del (p.Tyr153del),"Weaver syndrome (WVS)
                    ","Weaver Smith syndrome; Overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly"
EZH2,rs193921147,G,A,"missense_variant,coding_sequence_variant,genic_downstream_transcript_variant","A=0.000 (0/478, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs193921147,Pathogenic,RCV000023118.4,7q36.1,NM_004456.5(EZH2):c.2080C>T (p.His694Tyr),"Weaver syndrome (WVS)
                    ","Weaver Smith syndrome; Overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly"
EZH2,rs193921148,G,A,"missense_variant,coding_sequence_variant","A=0.000 (0/478, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs193921148,Pathogenic,RCV000023119.4,7q36.1,NM_004456.5(EZH2):c.394C>T (p.Pro132Ser),"Weaver syndrome (WVS)
                    ","Weaver Smith syndrome; Overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly"
EZH2,rs267601394,T,A,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs267601394,Likely-Pathogenic,RCV000422926.1,7q36.1,NM_004456.5(EZH2):c.1937A>T (p.Tyr646Phe),"Non-Hodgkin lymphoma (NHL)
                    ","Malignant lymphoma, non-Hodgkin; LYMPHOMA, NON-HODGKIN, SOMATIC"
EZH2,rs267601394,T,A,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs267601394,Likely-Pathogenic,RCV000430342.1,7q36.1,NM_004456.5(EZH2):c.1937A>T (p.Tyr646Phe),Lymphoma,MONDO: MONDO:0005062; MeSH: D008223; MedGen: C0024299; Orphanet: 223735; Human Phenotype Ontology: HP:0002665
EZH2,rs267601394,T,A,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs267601394,Likely-Pathogenic,RCV000440575.1,7q36.1,NM_004456.5(EZH2):c.1937A>T (p.Tyr646Phe),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
EZH2,rs267601394,T,G,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs267601394,Likely-Pathogenic,RCV000423969.1,7q36.1,NM_004456.5(EZH2):c.1937A>C (p.Tyr646Ser),Lymphoma,MONDO: MONDO:0005062; MeSH: D008223; MedGen: C0024299; Orphanet: 223735; Human Phenotype Ontology: HP:0002665
EZH2,rs267601394,T,G,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs267601394,Likely-Pathogenic,RCV000433156.1,7q36.1,NM_004456.5(EZH2):c.1937A>C (p.Tyr646Ser),"Non-Hodgkin lymphoma (NHL)
                    ","Malignant lymphoma, non-Hodgkin; LYMPHOMA, NON-HODGKIN, SOMATIC"
EZH2,rs267601394,T,G,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs267601394,Likely-Pathogenic,RCV000441670.1,7q36.1,NM_004456.5(EZH2):c.1937A>C (p.Tyr646Ser),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
EZH2,rs267601395,A,G,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs267601395,Likely-Pathogenic,RCV000418998.1,7q36.1,NM_004456.5(EZH2):c.1936T>C (p.Tyr646His),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
EZH2,rs267601395,A,G,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs267601395,Likely-Pathogenic,RCV000429291.1,7q36.1,NM_004456.5(EZH2):c.1936T>C (p.Tyr646His),Lymphoma,MONDO: MONDO:0005062; MeSH: D008223; MedGen: C0024299; Orphanet: 223735; Human Phenotype Ontology: HP:0002665
EZH2,rs267601395,A,G,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs267601395,Likely-Pathogenic,RCV000436489.1,7q36.1,NM_004456.5(EZH2):c.1936T>C (p.Tyr646His),"Non-Hodgkin lymphoma (NHL)
                    ","Malignant lymphoma, non-Hodgkin; LYMPHOMA, NON-HODGKIN, SOMATIC"
EZH2,rs267601395,A,T,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs267601395,Likely-Pathogenic,RCV000421839.1,7q36.1,NM_004456.5(EZH2):c.1936T>A (p.Tyr646Asn),Lymphoma,MONDO: MONDO:0005062; MeSH: D008223; MedGen: C0024299; Orphanet: 223735; Human Phenotype Ontology: HP:0002665
EZH2,rs267601395,A,T,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs267601395,Likely-Pathogenic,RCV000429270.1,7q36.1,NM_004456.5(EZH2):c.1936T>A (p.Tyr646Asn),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
EZH2,rs267601395,A,T,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs267601395,Likely-Pathogenic,RCV000439496.1,7q36.1,NM_004456.5(EZH2):c.1936T>A (p.Tyr646Asn),"Non-Hodgkin lymphoma (NHL)
                    ","Malignant lymphoma, non-Hodgkin; LYMPHOMA, NON-HODGKIN, SOMATIC"
EZH2,rs397515547,C,T,"missense_variant,genic_downstream_transcript_variant,coding_sequence_variant","T=0.000 (0/478, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs397515547,Pathogenic,RCV000055900.2,7q36.1,NM_004456.5(EZH2):c.2044G>A (p.Ala682Thr),"Weaver syndrome (WVS)
                    ","Weaver Smith syndrome; Overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly"
EZH2,rs397515548,C,T,"missense_variant,genic_downstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs397515548,Pathogenic,RCV000055901.2,7q36.1,NM_004456.5(EZH2):c.2233G>A (p.Glu745Lys),"Weaver syndrome (WVS)
                    ","Weaver Smith syndrome; Overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly"
EZH2,rs587783625,C,T,"coding_sequence_variant,missense_variant,genic_downstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs587783625,Pathogenic,RCV000145972.5,7q36.1,NM_004456.5(EZH2):c.1876G>A (p.Val626Met),"Weaver syndrome (WVS)
                    ","Weaver Smith syndrome; Overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly"
EZH2,rs587783626,G,A,"coding_sequence_variant,missense_variant,genic_downstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs587783626,Pathogenic,RCV000145975.9,7q36.1,NM_004456.5(EZH2):c.2050C>T (p.Arg684Cys),"Weaver syndrome (WVS)
                    ","Weaver Smith syndrome; Overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly"
EZH2,rs587783626,G,A,"coding_sequence_variant,missense_variant,genic_downstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs587783626,Pathogenic,RCV001564091.5,7q36.1,NM_004456.5(EZH2):c.2050C>T (p.Arg684Cys),none provided,MedGen: CN517202
EZH2,rs587783627,T,C,"coding_sequence_variant,missense_variant,genic_downstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs587783627,Likely-Pathogenic,RCV000145978.5,7q36.1,NM_004456.5(EZH2):c.2236A>G (p.Arg746Gly),"Weaver syndrome (WVS)
                    ","Weaver Smith syndrome; Overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly"
EZH2,rs797044844,T,C,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs797044844,Pathogenic,RCV000193211.2,7q36.1,NM_004456.5(EZH2):c.458A>G (p.Tyr153Cys),"Weaver syndrome (WVS)
                    ","Weaver Smith syndrome; Overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly"
EZH2,rs1057519833,G,C,"missense_variant,genic_downstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519833,Likely-Pathogenic,RCV000434252.1,7q36.1,NM_004456.5(EZH2):c.2045C>G (p.Ala682Gly),Lymphoma,MONDO: MONDO:0005062; MeSH: D008223; MedGen: C0024299; Orphanet: 223735; Human Phenotype Ontology: HP:0002665
EZH2,rs1057519894,T,A,"missense_variant,genic_downstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519894,Likely-Pathogenic,RCV000419957.1,7q36.1,NM_004456.5(EZH2):c.1922A>T (p.Glu641Val),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
EZH2,rs1057519894,T,A,"missense_variant,genic_downstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519894,Likely-Pathogenic,RCV000437178.1,7q36.1,NM_004456.5(EZH2):c.1922A>T (p.Glu641Val),"Non-Hodgkin lymphoma (NHL)
                    ","Malignant lymphoma, non-Hodgkin; LYMPHOMA, NON-HODGKIN, SOMATIC"
EZH2,rs1057519894,T,G,"missense_variant,genic_downstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519894,Likely-Pathogenic,RCV000429761.1,7q36.1,NM_004456.5(EZH2):c.1922A>C (p.Glu641Ala),"Non-Hodgkin lymphoma (NHL)
                    ","Malignant lymphoma, non-Hodgkin; LYMPHOMA, NON-HODGKIN, SOMATIC"
EZH2,rs1057519894,T,G,"missense_variant,genic_downstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519894,Likely-Pathogenic,RCV000436936.1,7q36.1,NM_004456.5(EZH2):c.1922A>C (p.Glu641Ala),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
FAM111B,rs551644836,A,C,"missense_variant,coding_sequence_variant","G=0.000004 (1/250758, GnomAD_exome).G=0.000008 (1/120932, ExAC).G=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs551644836#publications,Pathogenic,RCV000256249.4,11q12.1,NM_198947.4(FAM111B):c.1289A>C (p.Gln430Pro),Hereditary sclerosing poikiloderma with tendon and pulmonary involvement,"Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis"
FAM111B,rs587777236,T,G,"coding_sequence_variant,missense_variant","G=0.00000 (0/78698, PAGE_STUDY).G=0.000 (0/660, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs587777236,Pathogenic,RCV000106317.5,11q12.1,NM_198947.4(FAM111B):c.1861T>G (p.Tyr621Asp),Hereditary sclerosing poikiloderma with tendon and pulmonary involvement,"Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis"
FAM111B,rs587777236,T,G,"coding_sequence_variant,missense_variant","G=0.00000 (0/78698, PAGE_STUDY).G=0.000 (0/660, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs587777236,Likely-Pathogenic,RCV001268217.2,11q12.1,NM_198947.4(FAM111B):c.1861T>G (p.Tyr621Asp),none provided,MedGen: CN517202
FAM111B,rs587777237,A,G,"coding_sequence_variant,missense_variant","G=0.00000 (0/78700, PAGE_STUDY).G=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587777237,Pathogenic,RCV000106318.5,11q12.1,NM_198947.4(FAM111B):c.1879A>G (p.Arg627Gly),Hereditary sclerosing poikiloderma with tendon and pulmonary involvement,"Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis"
FAM111B,rs587777238,G,A,"coding_sequence_variant,missense_variant","A=0.00000 (0/78700, PAGE_STUDY).A=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587777238,Pathogenic,RCV000106319.5,11q12.1,NM_198947.4(FAM111B):c.1883G>A (p.Ser628Asn),Hereditary sclerosing poikiloderma with tendon and pulmonary involvement,"Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis"
FAM111B,rs886039851,AGA,delAGA,"inframe_deletion,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs886039851,Pathogenic,RCV000256336.4,11q12.1,NM_198947.4(FAM111B):c.1262_1264del (p.Lys421del),Hereditary sclerosing poikiloderma with tendon and pulmonary involvement,"Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis"
FAM111B,rs886039852,C,A,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs886039852,Pathogenic,RCV000256330.4,11q12.1,NM_198947.4(FAM111B):c.1874C>A (p.Thr625Asn),Hereditary sclerosing poikiloderma with tendon and pulmonary involvement,"Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis"
FAN1,rs387907279,C,T,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant,intron_variant,stop_gained","T=0.000016 (2/121276, ExAC).T=0.00010 (4/39898, ALFA).T=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs387907279#publications,Pathogenic,RCV000030744.6,15q13.3,NM_014967.5(FAN1):c.2245C>T (p.Arg749Ter),Karyomegalic interstitial nephritis,MONDO: MONDO:0013898; MedGen: C3553774; Orphanet: 401996; OMIM: 614817
FAN1,rs387907279,C,T,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant,intron_variant,stop_gained","T=0.000016 (2/121276, ExAC).T=0.00010 (4/39898, ALFA).T=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs387907279#publications,Pathogenic,RCV001852612.1,15q13.3,NM_014967.5(FAN1):c.2245C>T (p.Arg749Ter),none provided,MedGen: CN517202
FAN1,rs387907280,G,C,"intron_variant,genic_downstream_transcript_variant,coding_sequence_variant,missense_variant","A=0.000004 (1/264690, TOPMED).C=0.00001 (1/78280, PAGE_STUDY).A=0.00007 (1/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs387907280,Pathogenic,RCV000030748.6,15q13.3,NM_014967.5(FAN1):c.2809G>C (p.Gly937Arg),Karyomegalic interstitial nephritis,MONDO: MONDO:0013898; MedGen: C3553774; Orphanet: 401996; OMIM: 614817
FAN1,rs778075842,C,T,"genic_upstream_transcript_variant,upstream_transcript_variant,intron_variant,missense_variant,stop_gained,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.000004 (1/251432, GnomAD_exome).G=0.000008 (1/121412, ExAC)",1,https://www.ncbi.nlm.nih.gov/snp/rs778075842,Pathogenic,RCV000500635.1,15q13.3,NM_014967.5(FAN1):c.1102C>T (p.Gln368Ter),Karyomegalic interstitial nephritis,MONDO: MONDO:0013898; MedGen: C3553774; Orphanet: 401996; OMIM: 614817
FAN1,rs781134478,T,G,"genic_upstream_transcript_variant,upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.000004 (1/251146, GnomAD_exome).G=0.000008 (1/121148, ExAC)",1,https://www.ncbi.nlm.nih.gov/snp/rs781134478,Likely-Pathogenic,RCV000171228.1,15q13.3,NM_014967.5(FAN1):c.93T>G (p.Ile31Met),none provided,MedGen: CN517202
FANCA,rs17232973,G,T,"missense_variant,coding_sequence_variant,genic_downstream_transcript_variant,stop_gained","A=0.000203 (60/296100, ALFA).A=0.002550 (675/264690, TOPMED).A=0.000597 (150/251462, GnomAD_exome)",1,,Pathogenic,RCV001256487.1,16q24.3,NM_000135.4(FANCA):c.2021C>A (p.Ser674Ter),Fanconi anemia complementation group A,"Fanconi anemia, group A"
FANCA,rs142833057,G,A,"genic_downstream_transcript_variant,missense_variant,coding_sequence_variant","A=0.000021 (3/140260, GnomAD).T=0.00046 (13/28258, 14KJPN).T=0.00030 (5/16760, 8.3KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs142833057,Likely-Pathogenic,RCV000503023.7,16q24.3,NM_000135.4(FANCA):c.3482C>T (p.Thr1161Met),Fanconi anemia complementation group A,"Fanconi anemia, group A"
FANCA,rs147017625,G,A,"missense_variant,coding_sequence_variant,genic_downstream_transcript_variant","A=0.000880 (233/264690, TOPMED).A=0.000301 (71/235676, GnomAD_exome).A=0.000834 (117/140232, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs147017625,Likely-Pathogenic,RCV001843480.2,16q24.3,NM_000135.4(FANCA):c.3524C>T (p.Pro1175Leu),Hepatoblastoma,MONDO: MONDO:0018666; MedGen: C0206624; Human Phenotype Ontology: HP:0002884
FANCA,rs147176389,G,C,"missense_variant,coding_sequence_variant,stop_gained","A=0.000223 (59/264690, TOPMED).A=0.000044 (11/251006, GnomAD_exome).A=0.000171 (24/140242, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs147176389,Likely-Pathogenic,RCV001264295.1,16q24.3,NM_000135.4(FANCA):c.308C>G (p.Ser103Ter),Fanconi anemia complementation group A,"Fanconi anemia, group A"
FANCA,rs149551759,G,C,"missense_variant,coding_sequence_variant,stop_gained,genic_downstream_transcript_variant","A=0.000230 (61/264690, TOPMED).A=0.000379 (95/250708, GnomAD_exome).A=0.000338 (65/192586, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs149551759,Pathogenic,RCV000499830.6,16q24.3,NM_000135.4(FANCA):c.1340C>G (p.Ser447Ter),Fanconi anemia complementation group A,"Fanconi anemia, group A"
FANCA,rs149551759,G,C,"missense_variant,coding_sequence_variant,stop_gained,genic_downstream_transcript_variant","A=0.000230 (61/264690, TOPMED).A=0.000379 (95/250708, GnomAD_exome).A=0.000338 (65/192586, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs149551759,Pathogenic,RCV001857096.2,16q24.3,NM_000135.4(FANCA):c.1340C>G (p.Ser447Ter),"Fanconi anemia (FA)
                    ",Fanconi pancytopenia; Fanconi's anemia
FANCA,rs149797103,G,A,"synonymous_variant,coding_sequence_variant,genic_downstream_transcript_variant","A=0.000023 (6/264690, TOPMED).A=0.000097 (24/247702, GnomAD_exome).A=0.000064 (9/140264, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs149797103,Likely-Pathogenic,RCV000500885.5,16q24.3,NM_000135.4(FANCA):c.3624C>T (p.Ser1208=),Fanconi anemia complementation group A,"Fanconi anemia, group A"
FANCA,rs149797103,G,A,"synonymous_variant,coding_sequence_variant,genic_downstream_transcript_variant","A=0.000023 (6/264690, TOPMED).A=0.000097 (24/247702, GnomAD_exome).A=0.000064 (9/140264, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs149797103,Likely-Pathogenic,RCV000813304.6,16q24.3,NM_000135.4(FANCA):c.3624C>T (p.Ser1208=),"Fanconi anemia (FA)
                    ",Fanconi pancytopenia; Fanconi's anemia
FANCA,rs191943709,A,G,"genic_downstream_transcript_variant,coding_sequence_variant,missense_variant","G=0.000004 (1/264690, TOPMED).G=0.000036 (9/251442, GnomAD_exome).G=0.000007 (1/140262, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs191943709,Likely-Pathogenic,RCV000210699.4,16q24.3,NM_000135.4(FANCA):c.2941T>C (p.Cys981Arg),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
FANCA,rs397507553,GAA,delGAA,"3_prime_UTR_variant,inframe_insertion,genic_downstream_transcript_variant,coding_sequence_variant,inframe_deletion,non_coding_transcript_variant","delGAA=0.000132 (35/264690, TOPMED).delGAA=0.000100 (25/250632, GnomAD_exome).delGAA=0.000100 (14/140166, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs397507553,Pathogenic,RCV000033896.11,16q24.3,NM_000135.4(FANCA):c.3782TCT[2] (p.Phe1263del),Fanconi anemia complementation group A,"Fanconi anemia, group A"
FANCA,rs397507553,GAA,delGAA,"3_prime_UTR_variant,inframe_insertion,genic_downstream_transcript_variant,coding_sequence_variant,inframe_deletion,non_coding_transcript_variant","delGAA=0.000132 (35/264690, TOPMED).delGAA=0.000100 (25/250632, GnomAD_exome).delGAA=0.000100 (14/140166, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs397507553,Pathogenic,RCV000231918.10,16q24.3,NM_000135.4(FANCA):c.3782TCT[2] (p.Phe1263del),"Fanconi anemia (FA)
                    ",Fanconi pancytopenia; Fanconi's anemia
FANCA,rs397507553,GAA,delGAA,"3_prime_UTR_variant,inframe_insertion,genic_downstream_transcript_variant,coding_sequence_variant,inframe_deletion,non_coding_transcript_variant","delGAA=0.000132 (35/264690, TOPMED).delGAA=0.000100 (25/250632, GnomAD_exome).delGAA=0.000100 (14/140166, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs397507553,Pathogenic,RCV000485336.9,16q24.3,NM_000135.4(FANCA):c.3782TCT[2] (p.Phe1263del),none provided,MedGen: CN517202
FANCA,rs752160950,G,A,"genic_downstream_transcript_variant,stop_gained,coding_sequence_variant,missense_variant","A=0.000019 (5/264690, TOPMED).A=0.000014 (2/140270, GnomAD).A=0.000008 (1/121068, ExAC)",2,https://www.ncbi.nlm.nih.gov/snp/rs752160950,Pathogenic-Likely-Pathogenic,RCV000173013.6,16q24.3,NM_000135.4(FANCA):c.2557C>T (p.Arg853Ter),Fanconi anemia complementation group A,"Fanconi anemia, group A"
FANCA,rs752160950,G,A,"genic_downstream_transcript_variant,stop_gained,coding_sequence_variant,missense_variant","A=0.000019 (5/264690, TOPMED).A=0.000014 (2/140270, GnomAD).A=0.000008 (1/121068, ExAC)",2,https://www.ncbi.nlm.nih.gov/snp/rs752160950,Pathogenic,RCV000630944.6,16q24.3,NM_000135.4(FANCA):c.2557C>T (p.Arg853Ter),"Fanconi anemia (FA)
                    ",Fanconi pancytopenia; Fanconi's anemia
FANCA,rs772751654,T,A,"missense_variant,initiator_codon_variant","A=0.00011 (3/28254, 14KJPN).A=0.00006 (1/16756, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs772751654,Likely-Pathogenic,RCV000669511.2,16q24.3,NM_000135.4(FANCA):c.1A>T (p.Met1Leu),Fanconi anemia complementation group A,"Fanconi anemia, group A"
FANCA,rs772751654,T,A,"missense_variant,initiator_codon_variant","A=0.00011 (3/28254, 14KJPN).A=0.00006 (1/16756, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs772751654,Pathogenic,RCV001387726.6,16q24.3,NM_000135.4(FANCA):c.1A>T (p.Met1Leu),"Fanconi anemia (FA)
                    ",Fanconi pancytopenia; Fanconi's anemia
FANCA,rs772751654,T,C,"missense_variant,initiator_codon_variant","A=0.00011 (3/28254, 14KJPN).A=0.00006 (1/16756, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs772751654,Pathogenic,RCV000500370.9,16q24.3,NM_000135.4(FANCA):c.1A>G (p.Met1Val),Fanconi anemia complementation group A,"Fanconi anemia, group A"
FANCA,rs772751654,T,C,"missense_variant,initiator_codon_variant","A=0.00011 (3/28254, 14KJPN).A=0.00006 (1/16756, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs772751654,Pathogenic,RCV001383377.5,16q24.3,NM_000135.4(FANCA):c.1A>G (p.Met1Val),"Fanconi anemia (FA)
                    ",Fanconi pancytopenia; Fanconi's anemia
FANCA,rs772751654,T,G,"missense_variant,initiator_codon_variant","A=0.00011 (3/28254, 14KJPN).A=0.00006 (1/16756, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs772751654,Pathogenic-Likely-Pathogenic,RCV000668991.3,16q24.3,NM_000135.4(FANCA):c.1A>C (p.Met1Leu),Fanconi anemia complementation group A,"Fanconi anemia, group A"
FANCA,rs772751654,T,G,"missense_variant,initiator_codon_variant","A=0.00011 (3/28254, 14KJPN).A=0.00006 (1/16756, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs772751654,Pathogenic,RCV001861771.1,16q24.3,NM_000135.4(FANCA):c.1A>C (p.Met1Leu),"Fanconi anemia (FA)
                    ",Fanconi pancytopenia; Fanconi's anemia
